Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 44
1966 46
1967 45
1968 87
1969 76
1970 77
1971 83
1972 104
1973 140
1974 176
1975 137
1976 144
1977 198
1978 183
1979 199
1980 286
1981 96
1990 307
1991 512
1992 514
1993 610
1994 575
1995 631
1996 537
1997 455
1998 405
1999 319
2000 442
2001 390
2002 412
2003 364
2004 376
2005 395
2006 491
2007 390
2008 427
2009 505
2010 474
2011 547
2012 518
2013 558
2014 410
2015 367
2016 444
2017 514
2018 407
2019 400
2020 506
2021 666
2022 230
Text availability
Article attribute
Article type
Publication date

Search Results

15,968 results
Results by year
Filters applied: . Clear all
Page 1
Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial.
Smith MR, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Mohamed AF, Odom D, Bartsch J, Snapir A, Sarapohja T, Fizazi K. Smith MR, et al. Eur J Cancer. 2021 Sep;154:138-146. doi: 10.1016/j.ejca.2021.06.010. Epub 2021 Jul 14. Eur J Cancer. 2021. PMID: 34273811 Free article. Clinical Trial.
European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer.
van Kalsbeek RJ, van der Pal HJH, Kremer LCM, Bardi E, Brown MC, Effeney R, Winther JF, Follin C, den Hartogh J, Haupt R, Hjorth L, Kepak T, Kepakova K, Levitt G, Loonen JJ, Mangelschots M, Muraca M, Renard M, Sabic H, Schneider CU, Uyttebroeck A, Skinner R, Mulder RL. van Kalsbeek RJ, et al. Eur J Cancer. 2021 Sep;154:316-328. doi: 10.1016/j.ejca.2021.06.004. Epub 2021 Jul 29. Eur J Cancer. 2021. PMID: 34333209 Free article.
Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22).
Greimel E, Nagele E, Lanceley A, Oberguggenberger AS, Nordin A, Kuljanic K, Arraras JI, Wei-Chu C, Jensen PT, Tomaszewski KA, Creutzberg CL, Galalae R, Toelen H, Zimmermann K, Bjelic-Radisic V, Costantini A, Almont T, Serpentini S, Paskeviciute Frøding L, Vistad I, Schmalz C; EORTC Quality of Life Group. Greimel E, et al. Eur J Cancer. 2021 Sep;154:235-245. doi: 10.1016/j.ejca.2021.06.003. Epub 2021 Jul 20. Eur J Cancer. 2021. PMID: 34298374
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer.
Vergote I, Ray-Coquard I, Anderson DM, Cantuaria G, Colombo N, Garnier-Tixidre C, Gilbert L, Harter P, Hettle R, Lorusso D, Mäenpää J, Marth C, Matsumoto K, Ouwens M, Poveda A, Raspagliesi F, Rhodes K, Rubio Pérez MJ, Shapira-Frommer R, Shikama A, Sikorska M, Moore K, DiSilvestro P. Vergote I, et al. Eur J Cancer. 2021 Nov;157:415-423. doi: 10.1016/j.ejca.2021.08.023. Epub 2021 Sep 28. Eur J Cancer. 2021. PMID: 34597975 Free article. Clinical Trial.
15,968 results
You have reached the last available page of results. Please see the User Guide for more information.